Results from new Phase III study amongst women for corifollitropin alfa, an investigational fertility treatment for controlled ovarian stimulation
23 October 2012 | By Merck
New Phase III study presented...
List view / Grid view
News
Abbott announces new data evaluating mucosal healing with HUMIRA® (Adalimumab)
23 October 2012 | By Abbott
Results from a post-hoc sub-analysis...
AstraZeneca and Ironwood announce linaclotide collaboration for China
23 October 2012 | By AstraZeneca
AstraZeneca and Ironwood Pharmaceuticals, Inc. announced an agreement to co-develop and co-commercialise Ironwood’s linaclotide...
Rapid, high throughput preformulation with Avacta’s Optim® 1000
23 October 2012 | By kdm communications limited
Avacta Analytical’s Optim® 1000 is proving a valuable asset to scientists at the MVSC, University of Kansas, USA...
Lonza and OncoMed Pharmaceuticals sign a process development and manufacturing collaboration and multi-product GS license agreement
Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.
Abbott announces three-year long-term data evaluating efficacy with HUMIRA® (Adalimumab)
22 October 2012 | By Abbott
Results from an analysis of three-year long-term data...
Results from five phase III studies presented for GSK’s two candidate quadrivalent influenza vaccines
22 October 2012 | By GlaxoSmithKline
Results from five Phase III studies were presented at the IVW congress...
Pfizer to acquire NextWave Pharmaceuticals, Inc.
22 October 2012 | By Pfizer
Pfizer has announced its intention to acquire NextWave Pharmaceuticals...
Phase IIa laquinimod trial results show positive data for potential use in active crohn’s disease
22 October 2012 | By Teva Pharmaceutical Industries Ltd
TEVA and Active Biotech announced the presentation of Phase IIa clinical data...
Sirius Analytical product launch: Novel particle size analysis and digital image analysis combined
22 October 2012 | By Sirius Analytical Instruments Ltd
Sirius Analytical Instruments Ltd announces the introduction of a new product...
Tresiba® and Ryzodeg® receive positive opinions from the European regulatory authorities
19 October 2012 | By Novo Nordisk
Tresiba® and Ryzodeg® receive positive opinions...
Abbott receives positive opinion from CHMP for HUMIRA® use in pediatric crohn’s disease
19 October 2012 | By Abbott
The CHMP has adopted a positive opinion for HUMIRA®...
Japan’s Pharmaceuticals and Medical Devices Agency publishes assessment report of Tresiba®
19 October 2012 | By Novo Nordisk
Japan’s PMDA has published an assessment report of Tresiba®...
FDA Advisory Committee recommends KYNAMRO™ for homozygous familial hypercholesterolemia
18 October 2012 | By Sanofi
"We are very encouraged by the support for KYNAMRO..."
Biogen Idec receives notification of PDUFA date extension
18 October 2012 | By Biogen Idec
Biogen Idec announced that the U.S. FDA has extended the initial PDUFA date for its review...
